Add like
Add dislike
Add to saved papers

Oxidatively stable ferrocenyl-π-bridge-titanocene D-π-A complexes: an electrochemical and spectroscopic investigation of the mixed-valent states.

The synthesis, spectroscopic, and electrochemical characterization of oxidatively stable D-π-A compounds of the form (Me2CpC2Fc)2TiCl2 and RCp2Ti(C2Fc)2CuX (where Fc = ferrocenyl) are reported. Oxidative stability enabled by the addition of CuX is evidenced by voltammagrams of the RCp2Ti(C2Fc)2CuX compounds which all display two chemically-reversible 1e- FeIII/II couples, indicative of electronic communication between the Fc- termini. Differential pulse voltammetry (DPV) in CH2Cl2/[n-Bu4N][PF6], demonstrated that the redox potential difference between the two 1e- FeIII/II couples (ΔE1/2) is between 112 mV and 146 mV, being most pronounced with the electron rich Cp*2Ti(C2Fc)2CuBr. The ΔE1/2 values were unaffected by solvent (THF) and displayed only a small dependence on the identity of the counterion, either PF6- or B(C6F5)4-. For each complex with a measurable ΔE1/2 value, spectroelectrochemical experiments were performed in CH2Cl2/[n-Bu4N][PF6] and gave clear evidence of both the one-electron oxidized mixed-valent (MV) state and the two-electron oxidized state, each with distinct spectroscopic signatures. The MV states of these complexes showed absorbance between 820 and 940 nm which were replaced with a higher energy feature following a second oxidation. A very similar absorption band was also observed in the one-electron oxidized state of an analogue with only a single Fc substituent, namely TMSCp2Ti(C2Fc)(C2Ph)CuBr, suggesting this feature is not an FeII/FeIII intravalence charge-transfer (IVCT) band. Despite DFT calculations suggesting a pathway exists for electronic coupling, NIR spectroscopy on the MV states gave no evidence of an FeII/FeIII IVCT. Possible contributions to ΔE1/2 from inductive effects and a superexchange mechanism are discussed.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app